Asymmetric hydrogenation

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Asymmetric hydrogenation is a chemical reaction that adds two atoms of hydrogen to a target (substrate) molecule with three-dimensional spatial selectivity. Critically, this selectivity does not come from the target molecule itself, but from other reagents or catalysts present in the reaction. This allows spatial information (what chemists refer to as chirality) to transfer from one molecule to the target, forming the product as a single enantiomer. The chiral information is most commonly contained in a catalyst and, in this case, the information in a single molecule of catalyst may be transferred to many substrate molecules, amplifying the amount of chiral information present. Similar processes occur in nature, where a chiral molecule like an enzyme can catalyse the introduction of a chiral centre to give a product as a single enantiomer, such as amino acids, that a cell needs to function. By imitating this process, chemists can generate many novel synthetic molecules that interact with biological systems in specific ways, leading to new pharmaceutical agents and agrochemicals. The importance of asymmetric hydrogenation in both academia and industry contributed to two of its pioneers — William Standish Knowles and Ryōji Noyori — being awarded one half of the 2001 Nobel Prize in Chemistry.

A generic asymmetric hydrogenation of N-acetyl dehydroaminoacids


The history of asymmetric hydrogenation goes back to the early 1956 when a heterogeneous catalyst made of palladium deposited on silk was first used to successfully produce chiral hydrogenation products where one enantiomer was present in greater quantity than the other.[1] Later, in 1968, the groups of William Knowles and Leopold Horner independently published the first example of asymmetric hydrogenation using a homogeneous rhodium catalyst. While the enantiomeric excess, a quantity used to measure how much of one enantiomer is produced relative to the other, was low for both of these reactions, they were important demonstrations that asymmetric hydrogenation was possible and would encourage the rapid growth of the field. By 1972, an enantiomeric excess of 90% was possible and the first industrial synthesis using this technology, that of the Parkinson's drug L-DOPA, commenced.[2][3]


The field of asymmetric hydrogenation continued to experience a number of notable advances. Henri Kagan developed DIOP, a new type of chiral ligand (C2 symmetric ligands) that allowed chiral information to be transferred to substrates much more effectively. Ryōji Noyori introduced the use of ruthenium-based catalysts that could be used to asymmetrically hydrogenate several important types of substrates. The introduction of P,N ligands then further expanded the scope of asymmetric hydrogenation and demonstrated that the C2 symmetric ligands, while highly effective, are not fundamentally superior to chiral ligands lacking rotational symmetry.[4] Today, a large array of molecular architectures can be successfully modified by asymmetric hydrogenation. Homogeneous catalysts are certainly the most common and well developed type of catalyst used to achieve these reactions. However, researchers have begun to revisit heterogeneous catalysts and there, too, advances have been made.


Two major mechanisms have been proposed to date for catalytic hydrogenation with rhodium complexes: the unsaturated mechanism and the dihydride mechanism. While distinguishing between the two mechanisms is difficult, the difference between the two for asymmetric hydrogenation is relatively unimportant since both converge to a common intermediate before any stereochemical information is transferred to the product molecule.[5]

Convergent Mechanisms for Asymmetric Hydrogenation.svg

Proposed mechanisms for asymmetric hydrogenation

The preference for producing one enantiomer instead of another in these reactions may often be explained in terms of unfavourable steric interactions between certain portions of the ligand and the incoming prochiral substrate. Consideration of these interactions has led to the development of quadrant diagrams where "blocked" areas are denoted with a shaded box, while "open" areas are left unfilled. In the modeled reaction, large groups on an incoming olefin will tend to orient to fill the open areas of the diagram, while smaller groups will be directed to the blocked areas and hydrogen delivery will then occur to the back face of the olefin, fixing the stereochemistry. Note that only part of the chiral phosphine ligand is shown for the sake of clarity.

Comparative chemical diagrams

Quadrant model for asymmetric hydrogenation


Platinum-group metals[edit]

Rhodium was the first metal to be used in a homogeneous asymmetric hydrogenation,[6] and has since enjoyed considerable popularity in asymmetric hydrogenation. Targets for asymmetric hydrogenation with rhodium generally require a coordinating group close to the olefin.[5] While this is a significant chemical limitation, many classes of valuable industrial chemicals possess such functionalization and rhodium remains a highly useful metal for the asymmetric hydrogenation of these targets.[7]

The Noyori asymmetric hydrogenation is based on ruthenium.[8][9] Subsequent work has expanded upon Noyori's original catalyst template, leading to the inclusion of traditionally difficult substrates like t-butyl ketones[10] and 1-tetralones[11] as viable substrates for hydrogenation with ruthenium catalysts. Transfer hydrogenation based on the Ru and TsDPEN has also enjoyed commercial success.[12]

The development of iridium catalysts for asymmetric hydrogenation complements that of rhodium and ruthenium by targeting a number of "non-traditional" substrates for which good solutions had not been found.[13] Unfunctionalized olefins[14] are the archetypal case, but many other examples including ketones[15][16] exist. A common difficulty with iridium-based systems is their tendency to trimerize in solution,[16] and catalysts must be designed with a feature that prohibits this pathway. The use of a BArF anion has so far proven to be the most widely applicable solution;[16][17] other strategies to enhance catalyst stability include the addition of an additional coordinating arm to the chiral ligand,[15] increasing the steric bulk of the ligand,[18] using a dendrimeric ligand,[19] increasing the rigidity of the ligand,[20] immobilizing the ligand,[21] and using heterobimetallic systems (with iridium as one of the metals).[21]

Base metals[edit]

Iron is a popular research target for many catalytic processes, owing largely to its low cost and low toxicity relative to other transition metals.[22] Asymmetric hydrogenation methods using iron have been realized, although the rates and selectivity of these transformations does not equal those achieved with precious metals.[23] In some cases, structurally ill-defined nanoparticles have proven to be the active species in situ and the modest selectivity observed may result from their uncontrolled geometries.[24]

Ligand classes[edit]

Phosphine ligands[edit]

Chiral phosphine ligands are the source of chirality in most asymmetric hydrogenation catalysts. Of these the BINAP ligand is perhaps the best-known, as a result of its Nobel Prize-winning application in the Noyori asymmetric hydrogenation.[2]

Chiral phosphine ligands can be generally classified as mono- or bidentate. They can be further classified into those where the stereogenic centre is phosphorus or resides on the organic substituents. Ligands with a C2 symmetry element have been particularly popular, in part because the presence of such an element reduces the possible binding conformations of a substrate to a metal-ligand complex dramatically (often resulting in exceptional enantioselectivity).[25]

Monophosphine-type ligands were among the first to appear in asymmetric hydrogenation, with the ligand CAMP being involved in the first highly effective asymmetric hydrogenation.[26] Continued research into these types of ligands has explored both P-alkyl and P-heteroatom bonded ligands, with P-heteroatom ligands like the phosphites and phosphoramidites generally achieving more impressive results.[27] Structural classes of ligands that have been successful include those based on the binapthyl structure of MonoPHOS [28] or the spiro ring system of SiPHOS.[29] Notably, these monodentate ligands can be used in combination with each other to achieve a synergistic improvement in enantioselectivity;[30] something that is not possible with the diphosphine ligands.[27]

A chiral monophosphine derived from ferrocene
A ferrocene derivative
The historically important CAMP ligand
The CAMP ligand
A chiral monophosphine derived from BINOL
A BINOL derivative

The diphosphine-type ligands have received considerably more attention than the monophosphines and, perhaps as a consequence, have a much longer list of achievement. This class includes the first ligand to achieve high chiral selectivity (DIOP), the first ligand to be used in industrial asymmetric synthesis (DIPAMP[31][32][3]) and what is likely the best known chiral ligand (BINAP).[2] Their use in asymmetric hydrogenation is essentially ubiquitous and it is perhaps more common to find a highly effective asymmetric hydrogenation that uses a chiral diphosphine based system than it is to find one using an alternate ligand.

Three chemical diagrams

Historically important diphosphine ligands

P,N and P,O ligands[edit]

Generic PHOX ligand architecture
Effective ligand for various asymmetric-hydrogenation processes

The use of P,N ligands in asymmetric hydrogenation can be traced to the C2 symmetric bisoxazoline ligand.[33] However, these symmetric ligands were soon superseded by mono(oxazoline) ligands whose lack of C2 symmetry has in no way limited their efficacy as ligands for asymmetric catalysis.[34] Such ligands generally consist of an achiral nitrogen-containing heterocycle that is functionalized with a pendant phosphorus-containing arm, although both the exact nature of the heterocycle and the chemical environment phosphorus center has varied widely. No one structure has emerged as consistently effective with a broad range of substrates, although certain privileged structures (like the phosphine-oxazoline or PHOX architecture) have been established.[14][34][35] Moreover, within a narrowly defined substrate class the performance of metallic complexes with chiral P,N ligands can closely approach perfect conversion and selectivity in systems otherwise very difficult to target.[36]

The use of P,O ligands with transition metals in asymmetric hydrogenation is quite recent (2011). However, certain organometallic complexes derived from these ligands have shown promising results in the hydrogenation of α,β-unsaturated ketones and esters, with the complex shown displaying consistently high performance.[37]

NHC ligands[edit]

Chemical diagram
Catalyst developed by Burgess for asymmetric hydrogenation

Ligands for asymmetric hydrogenation based on an N-heterocyclic carbene (NHC) motif have so far generally fallen into one of two categories. The first are C,N ligands that combine an NHC with a chiral oxazoline to create a chiral chelating ligand,[38][39] while the second are chiral, C2 symmetric NHCs.[40]

NHC-based ligands of the first type have been generated as large libraries from the reaction of smaller libraries of individual NHCs and oxazolines.[38][39] The most effective catalyst of this type comes from the Burgess group, and featuring a bulky seven-membered metallocycle formed between the ligand and iridium. This complex has been applied to the catalytic hydrogenation of a number of unfunctionalized olefins[38] and vinyl ether alcohols[41] with conversions and ee's frequently in the high 80s or 90s. It has also been applied to the synthesis of a number of aldol,[42] vicinal dimethyl[43] and deoxypolyketide[44] motifs, and to the deoxypolyketides themselves.[45]

The second type of NHC ligands, C2 symmetric NHCs, have come to light quite recently but have shown themselves to be highly useful ligands for the asymmetric hydrogenation of traditionally difficult substrates like thiophenes (see below).

Linear substrates[edit]

The asymmetric hydrogenation of linear unsaturated molecules like olefins, ketones, enamines and imines represents the oldest and most-developed fields of research in asymmetric hydrogenation as a whole, and may be grouped together as "classic" substrates. Effective methods for these compounds often invoke a bidentate substrate binding mode, in which the target unsaturated group and a second, adjacent functionality bind the metal to form a precisely oriented chelate (which can then selectively receive hydrogen). Difficulties can arise, however, when this second (proximal, functional) group is not present. Unfunctionalized olefins and enamines are good examples of this, and have been the focus of modern research. Another difficulty can arise when substrates bind in an end-on, η1, fashion instead of in an η2 mode from the pi-face. This change removes the hydrogen-accepting carbon from the immediate binding environment about the metal, and has been presumed to make hydrogenation of compounds like imines and ketones more difficult.[46]

Unfunctionalized olefins and enamines[edit]

The asymmetric hydrogenations of functionalized olefins and enamines have traditionally been related because an enamide, (one of the most popular functionalized enamine targets) can be viewed much like a β-keto olefin (one of the most easily asymmetrically hydrogenated olefinic targets). The more challenging, unfunctionalized targets continue to share some effective systems, but have largely diverged in terms of favoured ligand types.

For unfunctionalized olefins, iridium metal sources (in conjunction with P,N-based ligands) form the dominant asymmetric hydrogenation systems. Catalyst utility within this category is unusually narrow; consequently, many different categories of solved and unsolved catalytic problems have developed. 1,1-disubstituted, 1,2-diaryl trisubstituted, 1,1,2-trialkyl and tetrasubstituted olefins represent classes that have been investigated separately,[47][48] and even within these classes variations may exist that make different solutions optimal.[49]

Two chemical diagrams

Example of asymmetric hydrogenation of unfunctionalized olefins

Chiral phosphoramidite and phosphonite ligands used in the asymmetric hydrogenation of enamines.

Conversely to the case of olefins, asymmetric hydrogenation of enamines has favoured diphosphine-type ligands; excellent results have been achieved with both iridium- and rhodium-based systems. However, even the best systems often suffer from either less-than-optimal enantioselectivity, a lack of generality or a combination of the two. Certain pyrrolidine-derived enamines of aromatic ketones may be asymmetrically hydrogenated using a cationic rhodium(I), chiral phosphonite ligand, and I2 and acetic acid system with ee values usually above 90% and potentially as high as 99.9%.[50] A similar system using iridium(I) and a very closely related phosphoramidite ligand was similarly effective for the asymmetric hydrogenation of pyrrolidine-type enamines where the double bond was inside the ring: in other words, of dihydropyrroles.[51] In both cases, the enantioselectivity dropped substantially when the ring size was increased from five to six.

Imines and ketones[edit]

Archetype of Noyori's catalysts for asymmetric hydrogenation of ketones

Ketones and imines are very closely related functional groups, and effective technologies for the asymmetric hydrogenation of each are also closely related. Of these, the ruthenium-chiral diphosphine-diamine system first elucidated by Noyori is perhaps one of the best known.[52] It can be employed in conjunction with a wide range of phosphines and amines (where the amine may be, but need not be, chiral) and can be easily adjusted for an optimal match with the target substrate, generally achieving enantiomeric excesses (ee's) above 90%.[53][54]

Iridium/P,N ligand-based systems are also commonly used for the asymmetric hydrogenation of ketones and imines. For example, a consistent system for benzylic aryl imines uses the P,N ligand SIPHOX in conjunction with iridium(I) in a cationic complex to achieve asymmetric hydrogenation with ee >90%.[20] One of the most efficient and effective catalysts ever developed for the asymmetric hydrogenation of ketones, with a turnover number (TON) up to 4,550,000 and ee up to 99.9%, uses another iridium(I) system with a closely related tridentate ligand.[15]

Two chemical diagrams

Highly effective system for the asymmetric hydrogenation of ketones

Despite their similarities, the two functional groups are not identical; there are many areas where they diverge significantly. One of these is in the asymmetric hydrogenation of N-unfunctionalized imines to give primary amines. Such species can be difficult to selectively reduce because they tend to exist in complex equilibria of imine and enamine tautomers, as well as (E) and (Z) isomers.[55] One approach to this problem has been to use ketimines as their hydrochloride salt and rely on the steric properties of the adjacent alkyl or aryl groups to allow the catalyst to differentiate between the two enantiotopic faces of the ketimine.[56][57]

Aromatic substrates[edit]

The asymmetric hydrogenation of aromatic (especially heteroaromatic), substrates is a very active field of ongoing research. Catalysts in this field must contend with a number of complicating factors, including the tendency of highly stable aromatic compounds to resist hydrogenation, the potential coordinating (and therefore catalyst-poisoning) abilities of both substrate and product, and the great diversity in substitution patterns that may be present on any one aromatic ring.[58] Of these substrates the most consistent success has been seen with nitrogen-containing heterocycles, where the aromatic ring is often activated either by protonation or by further functionalization of the nitrogen (generally with an electron-withdrawing protecting group). Such strategies are less applicable to oxygen- and sulfur-containing heterocycles, since they are both less basic and less nucleophilic; this additional difficulty may help to explain why few effective methods exist for their asymmetric hydrogenation.

Quinolines, isoquinolines and quinoxalines[edit]

Two systems exist for the asymmetric hydrogenation of 2-substituted quinolines with isolated yields generally greater than 80% and ee values generally greater than 90%. The first is an iridium(I)/chiral phosphine/I2 system, first reported by Zhou et al.[59] While the first chiral phosphine used in this system was MeOBiPhep, newer iterations have focused on improving the performance of this ligand. To this end, systems use phosphines (or related ligands) with improved air stability,[60] recyclability,[60] ease of preparation,[61] lower catalyst loading[19][62] and the potential role of achiral phosphine additives.[63] As of October 2012 no mechanism appears to have been proposed, although both the necessity of I2 or a halogen surrogate and the possible role of the heteroaromatic N in assisting reactivity have been documented.[58]

The second is an organocatalytic transfer hydrogenation system based on Hantzsh esters and a chiral Brønsted acid. In this case, the authors envision a mechanism where the isoquinoline is alternately protonated in an activating step, then reduced by conjugate addition of hydride from the Hantzsh ester.[59]

Several Chemical Diagrams

Proposed organocatalytic mechanism

Much of the asymmetric hydrogenation chemistry of quinoxalines is closely related to that of the structurally similar quinolines. Effective (and efficient) results can be obtained with an Ir(I)/phophinite/I2 system[64] and a Hantzsh ester-based organocatalytic system,[65] both of which are similar to the systems discussed earlier with regards to quinolines.


Pyridines are highly variable substrates for asymmetric reduction (even compared to other heteroaromatics), in that five carbon centers are available for differential substitution on the initial ring. As of October 2012 no method seems to exist that can control all five, although at least one reasonably general method exists.

The most-general method of asymmetric pyridine hydrogenation is actually a heterogeneous method, where asymmetry is generated from a chiral oxazolidinone bound to the C2 position of the pyridine. Hydrogenating such functionalized pyridines over a number of different heterogeneous metal catalysts gave the corresponding piperidine with the substituents at C3, C4, and C5 positions in an all-cis geometry, in high yield and excellent enantioselectivity. The oxazolidinone auxiliary is also conveniently cleaved under the hydrogenation conditions.[66]

Several chemical diagrams

Asymmetric hydrogenation of pyridines with heterogeneous catalyst

Methods designed specifically for 2-substituted pyridine hydrogenation can involve asymmetric systems developed for related substrates like 2-substituted quinolines and quinoxalines. For example, an iridium(I)\chiral phosphine\I2 system is effective in the asymmetric hydrogenation of activated (alkylated) 2-pyridiniums[67] or certain cyclohexanone-fused pyridines.[68] Similarly, chiral Brønsted acid catalysis with a Hantzsh ester as a hydride source is effective for some 2-alkyl pyridines with additional activating substitution.[69]


The asymmetric hydrogenation of indoles initially focused on N-protected indoles, where the protecting group could serve both to activate the heterocycle to hydrogenation and as a secondary coordination site for the metal. Later work allowed unprotected indoles to be targeted through Brønsted acid activation of the indole.

In the initial report on asymmetric indole hydrogenation, N-acetyl 2-substituted indoles could be protected with high yields and ee of 87-95%. 3-substituted indoles were less successful, with hydrolysis of the protecting group outcompeting the hydrogenation of the indole.[70] Switching to an N-tosyl protecting group inhibited the hydrolysis reaction and allowed both 2- and 3-substituted indoles to be hydrogenated in high yield and ee.[71][72] The problem with both methods, however, is that N-acetyl and N-tosyl groups require harsh cleavage conditions that might be incompatible with complex substrates. Using an easily cleaved N-Boc group would relieve this problem, and highly effective methods for the asymmetric hydrogenation of such indoles (both 2- and 3-substituted) were soon developed.[73][74]

Diagram of chemical process

Method for asymmetric hydrogenation of boc-protected indoles

Despite these advances in the asymmetric hydrogenation of protected indoles, considerable operational simplicity can be gained by removing the protecting group altogether. This has been achieved with catalytic systems utilizing Brønsted acids to activate the indole. The initial system used a Pd(TFA)2/H8-BINAP system to achieve the enantioselective cis-hydrogenation of 2,3- and 2-substituted indoles with high yield and excellent ee. A similar process, where sequential Friedel-Crafts alkylation and asymmetric hydrogenation occur in one pot, allow asymmetric 2,3-substituted indolines to be selectively prepared from 2-substituted indoles in similarly high yields and ee.[75][76]

Illustration of chemical process

Sequential alkylation and asymmetric hydrogenation of 2-substituted indoles

A promising organocatalytic method for the asymmetric hydrogenation of 2,3-substituted indoles utilizing a chiral Lewis base also exists, although the observed ee's are not quite equivalent to those of the metal-based hydrogenations.[75]


Achieving complete conversion of pyrroles to pyrrolidines by asymmetric hydrogenation has so far proven difficult, with partial-hydrogenation products often being observed.[77][78] Complete enantioselective reduction is possible, with the outcome depending on both the starting substrate and the method.

The asymmetric hydrogenation of 2,3,5-substituted pyrroles was achieved by the recognition that such substrates bear the same substitution pattern as 2-substituted indoles, and an asymmetric hydrogenation system that is effective for one of these substrates might be effective for both. Such an analysis led to the development of a ruthenium(I)/phosphine/amine base system for 2,3,5-substituted N-Boc pyrroles that can give either dihydro or tetrahydropyrroles (pyrrolidines), depending on the nature of the pyrrole substituents. An all-phenyl substitution pattern leads to dihydropyrroles in very high yield (>96%) and essentially perfect enantioselectivity. Access to the fully hydrogenated, all-cis dihydropyrrole may then be accessible through diastereoselective heterogeneous hydrogenation. Alkyl substitution may lead to either the dihydro or tetrahydropyrrole, although the yields (>70%) and enantioselectivities (often >90%) generally remain high. The regioselectivity in both cases appears to be governed by sterics, with the less-substituted double being preferentially hydrogenated.[77]

Asymmetric Hydrogenation of 2,3,5-substituted N-Boc Pyrroles.tif

The asymmetric hydrogenation of 2,3,5-substituted N-Boc pyrroles

Unprotected 2,5-pyrroles may also be hydrogenated asymmetrically by a Brønsted acid/Pd(II)/chiral phosphine-catalyzed method, to give the corresponding 2,5-disubstituted 1-pyrrolines in roughly 70-80% yield and 80-90% ee.[78]

Oxygen-containing heterocycles[edit]

The asymmetric hydrogenation of furans and benzofurans has so far proven highly challenging, with many systems reporting only moderately enantionselectivity with various systems.[79] Even in the case where good-to-excellent enantioselectivity has been obtained with a chiral P,N phosphinite ligand on a cationic iridium catalyst modeled after Crabtree's catalyst, the tested substrate scope is quite small and its applicability to a general furan architecture is uncertain.[80]

Asymmetric Hydrogenation of Benzofuran.png

The asymmetric hydrogenation of furans and benzofurans

Sulfur-containing heterocycles[edit]

As is the case with oxygen-containing heterocycles, the asymmetric hydrogenation of compounds where sulfur is part of the initial unsaturated pi-bonding system so far appears to be limited to thiophenes and benzothiophenes. The key approach to the asymmetric hydrogenation of these heterocycles involves a ruthenium(II) catalyst and chiral, C2 symmetric N-heterocyclic carbene (NHC). Interestingly, this system appears to possess superb selectivity (ee > 90%) and perfect diastereoselectivity (all cis) if the substrate has a fused (or directly bound) phenyl ring but yields only racemic product in all other tested cases.[81]

Asymmetric Hydrogenation of Thiophenes.tif

The asymmetric hydrogenation of thiophenes and benzothiophenes

Heterogeneous Catalysis[edit]

Research into asymmetric hydrogenation with heterogeneous catalysts has generally focused on three areas. The oldest, dating back to the first asymmetric hydrogenation with palladium deposited on a silk support, involves modifying a metal surface with a chiral molecule, usually one that can be harvested from nature. Alternatively, researchers have used various techniques to attempt to immobilize what would otherwise be homogeneous catalysts on heterogeneous supports or have used synthetic organic ligands and metal sources to build chiral metal-organic frameworks (MOFs).

Cinchonidine, one of the cinchona alkaloids

The greatest successes in chiral modification of metal surfaces have come from the use of cinchona alkaloids, though numerous other classes of natural products have been evaluated. These alkaloids have been shown to enhance the rate of substrate hydrogenation by 10–100 times, such that less than one molecule of cinchona alkaloid is needed for every reactive site on the metal and, in fact, the presence of too much of the chiral modifier can cause a decrease in the enantioselectivity of the reaction.[82]

An alternative technique and one that allows more control over the structural and electronic properties of active catalytic sites is the immobilization of catalysts that have been developed for homogeneous catalyis on a heterogeneous support. Covalent bonding of the catalyst to a polymer or other solid support is perhaps most common, though immobilization of the catalyst may also be achieved by adsorption onto a surface, ion exchange, or even physical encapsulation. One drawback of this approach is the potential for the proximity of the support to change the behaviour of the catalyst, lowering the enantioselectivity of the reaction. To avoid this, the catalyst is often bound to the support by a long linker though cases are known where the proximity of the support can actually enhance the performance of the catalyst.[82]

The final approach involves the construction of MOFs that incorporate chiral reaction sites from a number of different components, potentially including chiral and achiral organic ligands, structural metal ions, catalytically active metal ions, and/or preassembled catalytically active organometallic cores.[83] This field is relatively new, and few examples exist of chiral asymmetric hydrogenation using these frameworks. One of these was reported in 2003, when a heterogeneous catalyst was reported that included structural zirconium, catalytically active ruthenium, and a BINAP-derived phosphonate as both chiral ligand and structural linker. As little as 0.005 mol% of this catalyst proved sufficient to achieve the asymmetric hydrogenation of aryl ketones, though the usual conditions featured 0.1 mol % of catalyst and resulted in an enantiomeric excess of 90.6–99.2%.[84]

ZrPhosphonate Heterogeneous Catalyst for Asymmetric Hydrogenation of Aryl Ketones.png

The active site of a heterogeneous zirconium phosphonate catalyst for asymmetric hydrogenation

Industrial applications[edit]

(S,S)-Ro 67-8867

Knowles' research into asymmetric hydrogenation and its application to the production scale synthesis of L-Dopa[3] gave asymmetric hydrogenation a strong start in the industrial world. More recently, a 2001 review indicated that asymmetric hydrogenation accounted for 50% of production scale, 90% of pilot scale, and 74% of bench scale catalytic, enantioselective processes in industry, with the caveat that asymmetric catalytic methods in general were not yet widely used.[85]

The success of asymmetric hydrogenation in industry can be seen in a number of specific cases where the replacement of kinetic resolution based methods has resulted in substantial improvements in the process's efficiency. For example, Roche's Catalysis Group was able to achieve the synthesis of (S,S)-Ro 67-8867 in 53% overall yield, a dramatic increase above the 3.5% that was achieved in the resolution based synthesis.[86] Roche's synthesis of mibefradil was likewise improved by replacing resolution with asymmetric hydrogenation, reducing the step count by three and increasing the yield of a key intermediate to 80% from the original 70%.[87]

Partial Roche Synthesis of Mibefradil.tif

Asymmetric hydrogenation in the industrial synthesis of mibefradil


  1. ^ Akabori, S.; Sakurai, S.; Izumi, Y.; Fujii, Y. (1956). "An Asymmetric Catalyst". Nature 178 (4528): 323. doi:10.1038/178323b0. PMID 13358737.  edit
  2. ^ a b c Noyori, R. (2003). "Asymmetric Catalysis: Science and Opportunities (Nobel Lecture 2001)". Advanced Synthesis & Catalysis 345 (12): 15–41. doi:10.1002/adsc.200390002.  edit
  3. ^ a b c Knowles, W. S. (2002). "Asymmetric Hydrogenations (Nobel Lecture)". Angewandte Chemie International Edition 41 (12): 1998–2007. doi:10.1002/1521-3773(20020617)41:12<1998::AID-ANIE1998>3.0.CO;2-8.  edit
  4. ^ Pfaltz, A. (2004). "Asymmetric Catalysis Special Feature Part II: Design of chiral ligands for asymmetric catalysis: From C2-symmetric P,P- and N,N-ligands to sterically and electronically nonsymmetrical P,N-ligands". Proceedings of the National Academy of Sciences 101 (16): 5723–5726. doi:10.1073/pnas.0307152101.  edit
  5. ^ a b Gridnev, I. D.; Imamoto, T. (2004). "On the Mechanism of Stereoselection in Rh-Catalyzed Asymmetric Hydrogenation:  A General Approach for Predicting the Sense of Enantioselectivity". Accounts of Chemical Research 37 (9): 633–644. doi:10.1021/ar030156e. PMID 15379579.  edit
  6. ^ Knowles, W. S.; Sabacky, M. J. (1968). "Catalytic asymmetric hydrogenation employing a soluble, optically active, rhodium complex". Chemical Communications (London) (22): 1445. doi:10.1039/C19680001445.  edit
  7. ^ Pilkington, C.; Lennon, I. (2003). "The Application of Asymmetric Hydrogenation for the Manufacture of Pharmaceutical­ Intermediates:The Need for Catalyst Diversity". Synthesis 2003 (11): 1639. doi:10.1055/s-2003-40871.  edit
  8. ^ Miyashita, A.; Yasuda, A.; Takaya, H.; Toriumi, K.; Ito, T.; Souchi, T.; Noyori, R. (1980). "Synthesis of 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP), an atropisomeric chiral bis(triaryl)phosphine, and its use in the rhodium(I)-catalyzed asymmetric hydrogenation of .alpha.-(acylamino)acrylic acids". Journal of the American Chemical Society 102 (27): 7932. doi:10.1021/ja00547a020.  edit
  9. ^ Noyori, R.; Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. (1987). "Asymmetric hydrogenation of .beta.-keto carboxylic esters. A practical, purely chemical access to .beta.-hydroxy esters in high enantiomeric purity". Journal of the American Chemical Society 109 (19): 5856. doi:10.1021/ja00253a051.  edit
  10. ^ Ohkuma, Takeshi; Sandoval, Christian A.; Srinivasan, Rajagopal; Lin, Quinghong; Wei, Yinmao; Muñiz, Kilian; Noyori, Ryoji (2005-06-01). "Asymmetric Hydrogenation of tert-Alkyl Ketones". Journal of the American Chemical Society (American Chemical Society) 127 (23). doi:10.1021/ja052071. ISSN 0002-7863.  edit
  11. ^ Ohkuma, T.; Hattori, T.; Ooka, H.; Inoue, T.; Noyori, R. (2004). "BINAP/1,4-Diamine−Ruthenium(II) Complexes for Efficient Asymmetric Hydrogenation of 1-Tetralones and Analogues". Organic Letters 6 (16): 2681–2683. doi:10.1021/ol049157c. PMID 15281743.  edit
  12. ^ Ikariya, T.; Blacker, A. J. (2007). "Asymmetric Transfer Hydrogenation of Ketones with Bifunctional Transition Metal-Based Molecular Catalysts†". Accounts of Chemical Research 40 (12): 1300–1308. doi:10.1021/ar700134q. PMID 17960897.  edit
  13. ^ Church, T. L.; Andersson, P. G. (2008). "Iridium catalysts for the asymmetric hydrogenation of olefins with nontraditional functional substituents". Coordination Chemistry Reviews 252 (5–7): 513. doi:10.1016/j.ccr.2007.09.015.  edit
  14. ^ a b Lightfoot, A.; Schnider, P.; Pfaltz, A. (1998). "Enantioselective Hydrogenation of Olefins with Iridium-Phosphanodihydrooxazole Catalysts". Angewandte Chemie International Edition 37 (20): 2897. doi:10.1002/(SICI)1521-3773(19981102)37:20<2897::AID-ANIE2897>3.0.CO;2-8.  edit
  15. ^ a b c Xie, J. H.; Liu, X. Y.; Xie, J. B.; Wang, L. X.; Zhou, Q. L. (2011). "An Additional Coordination Group Leads to Extremely Efficient Chiral Iridium Catalysts for Asymmetric Hydrogenation of Ketones". Angewandte Chemie International Edition 50 (32): 7329. doi:10.1002/anie.201102710.  edit
  16. ^ a b c Pfaltz, A.; Blankenstein, J. R.; Hilgraf, R.; Hörmann, E.; McIntyre, S.; Menges, F.; Schönleber, M.; Smidt, S. P.; Wüstenberg, B.; Zimmermann, N. (2003). "Iridium-Catalyzed Enantioselective Hydrogenation of Olefins". Advanced Synthesis & Catalysis 345 (12): 33. doi:10.1002/adsc.200390027.  edit
  17. ^ Cui, X.; Burgess, K. (2005). "Catalytic Homogeneous Asymmetric Hydrogenations of Largely Unfunctionalized Alkenes". Chemical Reviews 105 (9): 3272–3296. doi:10.1021/cr0500131. PMID 16159153.  edit
  18. ^ Xu, Y.; Mingos, D. M. P.; Brown, J. M. (2008). "Crabtree's catalyst revisited; Ligand effects on stability and durability". Chemical Communications (2): 199. doi:10.1039/B711979H.  edit
  19. ^ a b Wang, Z. J.; Deng, G. J.; Li, Y.; He, Y. M.; Tang, W. J.; Fan, Q. H. (2007). "Enantioselective Hydrogenation of Quinolines Catalyzed by Ir(BINAP)-Cored Dendrimers:  Dramatic Enhancement of Catalytic Activity". Organic Letters 9 (7): 1243–1246. doi:10.1021/ol0631410. PMID 17328554.  edit
  20. ^ a b Zhu, S. F.; Xie, J. B.; Zhang, Y. Z.; Li, S.; Zhou, Q. L. (2006). "Well-Defined Chiral Spiro Iridium/Phosphine−Oxazoline Cationic Complexes for Highly Enantioselective Hydrogenation of Imines at Ambient Pressure". Journal of the American Chemical Society 128 (39): 12886–12891. doi:10.1021/ja063444p. PMID 17002383.  edit
  21. ^ a b Blaser, H. U.; Pugin, B. T.; Spindler, F.; Togni, A. (2002). "Enantioselective imine hydrogenation with Ir diphosphine catalysts: Fighting deactivation". Comptes Rendus Chimie 5 (5): 379. doi:10.1016/S1631-0748(02)01391-7.  edit
  22. ^ Enthaler, S.; Junge, K.; Beller, M. (2008). "Sustainable Metal Catalysis with Iron: From Rust to a Rising Star?". Angewandte Chemie International Edition 47 (18): 3317. doi:10.1002/anie.200800012.  edit
  23. ^ Mikhailine, A.; Lough, A. J.; Morris, R. H. (2009). "Efficient Asymmetric Transfer Hydrogenation of Ketones Catalyzed by an Iron Complex Containing a P−N−N−P Tetradentate Ligand Formed by Template Synthesis". Journal of the American Chemical Society 131 (4): 1394–1395. doi:10.1021/ja809493h. PMID 19133772.  edit
  24. ^ Sonnenberg, J. F.; Coombs, N.; Dube, P. A.; Morris, R. H. (2012). "Iron Nanoparticles Catalyzing the Asymmetric Transfer Hydrogenation of Ketones". Journal of the American Chemical Society 134 (13): 5893–5899. doi:10.1021/ja211658t. PMID 22448656.  edit
  25. ^ Whitesell, J. K. (1989). "C2 symmetry and asymmetric induction". Chemical Reviews 89 (7): 1581–1590. doi:10.1021/cr00097a012.  edit
  26. ^ Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. (1972). "Catalytic asymmetric hydrogenation". Journal of the Chemical Society, Chemical Communications: 10. doi:10.1039/C39720000010.  edit
  27. ^ a b Jerphagnon, T.; Renaud, J. L.; Bruneau, C. (2004). "Chiral monodentate phosphorus ligands for rhodium-catalyzed asymmetric hydrogenation". Tetrahedron: Asymmetry 15 (14): 2101. doi:10.1016/j.tetasy.2004.04.037.  edit
  28. ^ Van Den Berg, M.; Minnaard, A. J.; Schudde, E. P.; Van Esch, J.; De Vries, A. H. M.; De Vries, J. G.; Feringa, B. L. (2000). "Highly Enantioselective Rhodium-Catalyzed Hydrogenation with Monodentate Ligands". Journal of the American Chemical Society 122 (46): 11539. doi:10.1021/ja002507f.  edit
  29. ^ Fu, Y.; Xie, J. H.; Hu, A. G.; Zhou, H.; Wang, L. X.; Zhou, Q. L. (2002). "Novel monodentate spiro phosphorus ligands for rhodium-catalyzed hydrogenation reactions". Chemical Communications (5): 480. doi:10.1039/B109827F.  edit
  30. ^ Reetz, M. T.; Sell, T.; Meiswinkel, A.; Mehler, G. (2003). "A New Principle in Combinatorial Asymmetric Transition-Metal Catalysis: Mixtures of Chiral Monodentate P Ligands". Angewandte Chemie International Edition 42 (7): 790. doi:10.1002/anie.200390209.  edit
  31. ^ Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman, G. L.; Weinkauff, D. J. (1977). "Asymmetric hydrogenation. Rhodium chiral bisphosphine catalyst". Journal of the American Chemical Society 99 (18): 5946. doi:10.1021/ja00460a018.  edit
  32. ^ Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D.; Weinkauff, D. J. (1975). "Asymmetric hydrogenation with a complex of rhodium and a chiral bisphosphine". Journal of the American Chemical Society 97 (9): 2567. doi:10.1021/ja00842a058.  edit
  33. ^ Müller, D.; Umbricht, G.; Weber, B.; Pfaltz, A. (1991). "C2-Symmetric 4,4',5,5'-Tetrahydrobi(oxazoles) and 4,4',5,5'-Tetrahydro-2,2'-methylenebis[oxazoles] as Chiral Ligands for Enantioselective Catalysis Preliminary Communication". Helvetica Chimica Acta 74: 232. doi:10.1002/hlca.19910740123.  edit
  34. ^ a b Helmchen, G. N.; Pfaltz, A. (2000). "PhosphinooxazolinesA New Class of Versatile, Modular P,N-Ligands for Asymmetric Catalysis". Accounts of Chemical Research 33 (6): 336–345. doi:10.1021/ar9900865. PMID 10891051.  edit
  35. ^ Franzke, A.; Pfaltz, A. (2011). "Zwitterionic Iridium Complexes with P,N-Ligands as Catalysts for the Asymmetric Hydrogenation of Alkenes". Chemistry - A European Journal 17 (15): 4131. doi:10.1002/chem.201003314.  edit
  36. ^ Maurer, F.; Huch, V.; Ullrich, A.; Kazmaier, U. (2012). "Development of Catalysts for the Stereoselective Hydrogenation of α,β-Unsaturated Ketones". The Journal of Organic Chemistry 77 (11): 5139–5143. doi:10.1021/jo300246c. PMID 22571628.  edit
  37. ^ Rageot, D.; Woodmansee, D. H.; Pugin, B. T.; Pfaltz, A. (2011). "Proline-Based P,O Ligand/Iridium Complexes as Highly Selective Catalysts: Asymmetric Hydrogenation of Trisubstituted Alkenes". Angewandte Chemie International Edition 50 (41): 9598. doi:10.1002/anie.201104105.  edit
  38. ^ a b c Perry, M. C.; Cui, X.; Powell, M. T.; Hou, D. R.; Reibenspies, J. H.; Burgess, K. (2003). "Optically Active Iridium Imidazol-2-ylidene-oxazoline Complexes:  Preparation and Use in Asymmetric Hydrogenation of Arylalkenes". Journal of the American Chemical Society 125 (1): 113–123. doi:10.1021/ja028142b. PMID 12515512.  edit
  39. ^ a b Nanchen, S.; Pfaltz, A. (2006). "Synthesis and Application of ChiralN-Heterocyclic Carbene–Oxazoline Ligands: Iridium-Catalyzed Enantioselective Hydrogenation". Chemistry - A European Journal 12 (17): 4550. doi:10.1002/chem.200501500.  edit
  40. ^ Urban, S.; Ortega, N.; Glorius, F. (2011). "Ligand-Controlled Highly Regioselective and Asymmetric Hydrogenation of Quinoxalines Catalyzed by Ruthenium N-Heterocyclic Carbene Complexes". Angewandte Chemie International Edition 50 (16): 3803. doi:10.1002/anie.201100008.  edit
  41. ^ Zhu, Y.; Burgess, K. (2008). "Iridium-Catalyzed Asymmetric Hydrogenation of Vinyl Ethers". Advanced Synthesis & Catalysis 350 (7–8): 979. doi:10.1002/adsc.200700546.  edit
  42. ^ Zhao, J.; Burgess, K. (2009). "Aldol-Type Chirons from Asymmetric Hydrogenations of Trisubstituted Alkenes". Organic Letters 11 (10): 2053–2056. doi:10.1021/ol900308w. PMID 19368378.  edit
  43. ^ Zhao, J.; Burgess, K. (2009). "Synthesis of Vicinal Dimethyl Chirons by Asymmetric Hydrogenation of Trisubstituted Alkenes". Journal of the American Chemical Society 131 (37): 13236–13237. doi:10.1021/ja905458n. PMID 19719102.  edit
  44. ^ Zhou, J.; Burgess, K. (2007). "Α,ω-Functionalized 2,4-Dimethylpentane Dyads and 2,4,6-Trimethylheptane Triads through Asymmetric Hydrogenation". Angewandte Chemie International Edition 46 (7): 1129. doi:10.1002/anie.200603635.  edit
  45. ^ Zhou, J.; Zhu, Y.; Burgess, K. (2007). "Synthesis of (S,R,R,S,R,S)-4,6,8,10,16,18- Hexamethyldocosane fromAntitrogusparvulusvia Diastereoselective Hydrogenations". Organic Letters 9 (7): 1391–1393. doi:10.1021/ol070298z. PMID 17338543.  edit
  46. ^ Noyori, R.; Yamakawa, M.; Hashiguchi, S. (2001). "Metal−Ligand Bifunctional Catalysis:  A Nonclassical Mechanism for Asymmetric Hydrogen Transfer between Alcohols and Carbonyl Compounds". The Journal of Organic Chemistry 66 (24): 7931–7944. doi:10.1021/jo010721w. PMID 11722188.  edit
  47. ^ Pàmies, O.; Andersson, P. G.; Diéguez, M. (2010). "Asymmetric Hydrogenation of Minimally Functionalised Terminal Olefins: An Alternative Sustainable and Direct Strategy for Preparing Enantioenriched Hydrocarbons". Chemistry - A European Journal 16 (48): 14232. doi:10.1002/chem.201001909.  edit
  48. ^ Woodmansee, D. H.; Pfaltz, A. (2011). "Asymmetric hydrogenation of alkenes lacking coordinating groups". Chemical Communications 47 (28): 7912–7916. doi:10.1039/c1cc11430a. PMID 21556431.  edit
  49. ^ Mazuela, J.; Verendel, J. J.; Coll, M.; SchäFfner, B. N.; BöRner, A.; Andersson, P. G.; PàMies, O.; DiéGuez, M. (2009). "Iridium Phosphite−Oxazoline Catalysts for the Highly Enantioselective Hydrogenation of Terminal Alkenes". Journal of the American Chemical Society 131 (34): 12344–12353. doi:10.1021/ja904152r. PMID 19658416.  edit
  50. ^ Hou, G. H.; Xie, J. H.; Wang, L. X.; Zhou, Q. L. (2006). "Highly Efficient Rh(I)-Catalyzed Asymmetric Hydrogenation of Enamines Using Monodente Spiro Phosphonite Ligands". Journal of the American Chemical Society 128 (36): 11774–11775. doi:10.1021/ja0644778. PMID 16953614.  edit
  51. ^ Hou, G. H.; Xie, J. H.; Yan, P. C.; Zhou, Q. L. (2009). "Iridium-Catalyzed Asymmetric Hydrogenation of Cyclic Enamines". Journal of the American Chemical Society 131 (4): 1366–1367. doi:10.1021/ja808358r. PMID 19132836.  edit
  52. ^ Ohkuma, T.; Ooka, H.; Hashiguchi, S.; Ikariya, T.; Noyori, R. (1995). "Practical Enantioselective Hydrogenation of Aromatic Ketones". Journal of the American Chemical Society 117 (9): 2675. doi:10.1021/ja00114a043.  edit
  53. ^ Noyori, R.; Ohkuma, T. (2001). "Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones". Angewandte Chemie International Edition 40: 40. doi:10.1002/1521-3773(20010105)40:1<40::AID-ANIE40>3.0.CO;2-5.  edit
  54. ^ Hems, W. P.; Groarke, M.; Zanotti-Gerosa, A.; Grasa, G. A. (2007). "\(Bisphosphine) Ru(II) Diamine] Complexes in Asymmetric Hydrogenation: Expanding the Scope of the Diamine Ligand". Accounts of Chemical Research 40 (12): 1340–1347. doi:10.1021/ar7000233. PMID 17576143.  edit
  55. ^ Yu, Z.; Jin, W.; Jiang, Q. (2012). "Brønsted Acid Activation Strategy in Transition-Metal Catalyzed Asymmetric Hydrogenation of N-Unprotected Imines, Enamines, and N-Heteroaromatic Compounds". Angewandte Chemie International Edition 51 (25): 6060. doi:10.1002/anie.201200963.  edit
  56. ^ Hou, G.; Gosselin, F.; Li, W.; McWilliams, J. C.; Sun, Y.; Weisel, M.; O'Shea, P. D.; Chen, C. Y.; Davies, I. W.; Zhang, X. (2009). "Enantioselective Hydrogenation of N−H Imines". Journal of the American Chemical Society 131 (29): 9882–9883. doi:10.1021/ja903319r. PMID 19569686.  edit
  57. ^ Hou, G.; Tao, R.; Sun, Y.; Zhang, X.; Gosselin, F. (2010). "Iridium−Monodentate Phosphoramidite-Catalyzed Asymmetric Hydrogenation of Substituted Benzophenone N−H Imines". Journal of the American Chemical Society 132 (7): 2124–2125. doi:10.1021/ja909583s. PMID 20104899.  edit
  58. ^ a b Zhou, Y. G. (2007). "Asymmetric Hydrogenation of Heteroaromatic Compounds". Accounts of Chemical Research 40 (12): 1357–1366. doi:10.1021/ar700094b. PMID 17896823.  edit
  59. ^ a b Wang, W. B.; Lu, S. M.; Yang, P. Y.; Han, X. W.; Zhou, Y. G. (2003). "Highly Enantioselective Iridium-Catalyzed Hydrogenation of Heteroaromatic Compounds, Quinolines". Journal of the American Chemical Society 125 (35): 10536–10537. doi:10.1021/ja0353762. PMID 12940733.  edit
  60. ^ a b Xu, L.; Lam, K. H.; Ji, J.; Wu, J.; Fan, Q. H.; Lo, W. H.; Chan, A. S. C. (2005). "Air-stable Ir-(P-Phos) complex for highly enantioselective hydrogenation of quinolines and their immobilization in poly(ethylene glycol) dimethyl ether (DMPEG)". Chemical Communications (11): 1390. doi:10.1039/B416397D.  edit
  61. ^ Lam, K. H.; Xu, L.; Feng, L.; Fan, Q. H.; Lam, F. L.; Lo, W. H.; Chan, A. S.  C. (2005). "Highly Enantioselective Iridium-Catalyzed Hydrogenation of Quinoline Derivatives Using Chiral Phosphinite H8-BINAPO". Advanced Synthesis & Catalysis 347 (14): 1755. doi:10.1002/adsc.200505130.  edit
  62. ^ Qiu, L.; Kwong, F. Y.; Wu, J.; Lam, W. H.; Chan, S.; Yu, W. Y.; Li, Y. M.; Guo, R.; Zhou, Z.; Chan, A. S. C. (2006). "A New Class of Versatile Chiral-Bridged Atropisomeric Diphosphine Ligands:  Remarkably Efficient Ligand Syntheses and Their Applications in Highly Enantioselective Hydrogenation Reactions". Journal of the American Chemical Society 128 (17): 5955–5965. doi:10.1021/ja0602694. PMID 16637664.  edit
  63. ^ Reetz, M. T.; Li, X. (2006). "Asymmetric hydrogenation of quinolines catalyzed by iridium complexes of BINOL-derived diphosphonites". Chemical Communications (20): 2159. doi:10.1039/b602320g.  edit
  64. ^ Tang, W.; Xu, L.; Fan, Q. H.; Wang, J.; Fan, B.; Zhou, Z.; Lam, K. H.; Chan, A. S. C. (2009). "Asymmetric Hydrogenation of Quinoxalines with Diphosphinite Ligands: A Practical Synthesis of Enantioenriched, Substituted Tetrahydroquinoxalines". Angewandte Chemie International Edition 48 (48): 9135. doi:10.1002/anie.200904518.  edit
  65. ^ Rueping, M.; Tato, F.; Schoepke, F.  R. (2010). "The First General, Efficient and Highly Enantioselective Reduction of Quinoxalines and Quinoxalinones". Chemistry - A European Journal 16 (9): 2688. doi:10.1002/chem.200902907.  edit
  66. ^ Glorius, F.; Spielkamp, N.; Holle, S.; Goddard, R.; Lehmann, C. W. (2004). "Efficient Asymmetric Hydrogenation of Pyridines". Angewandte Chemie International Edition 43 (21): 2850. doi:10.1002/anie.200453942.  edit
  67. ^ Ye, Z. S.; Chen, M. W.; Chen, Q. A.; Shi, L.; Duan, Y.; Zhou, Y. G. (2012). "Iridium-Catalyzed Asymmetric Hydrogenation of Pyridinium Salts". Angewandte Chemie International Edition 51 (40): 10181. doi:10.1002/anie.201205187.  edit
  68. ^ Tang, W. J.; Tan, J.; Xu, L. J.; Lam, K. H.; Fan, Q. H.; Chan, A. S.  C. (2010). "Highly Enantioselective Hydrogenation of Quinoline and Pyridine Derivatives with Iridium-(P-Phos) Catalyst". Advanced Synthesis & Catalysis 352 (6): 1055. doi:10.1002/adsc.200900870.  edit
  69. ^ Rueping, M.; Antonchick, A. P. (2007). "Organocatalytic Enantioselective Reduction of Pyridines". Angewandte Chemie International Edition 46 (24): 4562. doi:10.1002/anie.200701158.  edit
  70. ^ Kuwano, R.; Sato, K.; Kurokawa, T.; Karube, D.; Ito, Y. (2000). "Catalytic Asymmetric Hydrogenation of Heteroaromatic Compounds, Indoles". Journal of the American Chemical Society 122 (31): 7614. doi:10.1021/ja001271c.  edit
  71. ^ Kuwano, R.; Kaneda, K.; Ito, T.; Sato, K.; Kurokawa, T.; Ito, Y. (2004). "Highly Enantioselective Synthesis of Chiral 3-Substituted Indolines by Catalytic Asymmetric Hydrogenation of Indoles". Organic Letters 6 (13): 2213–2215. doi:10.1021/ol049317k. PMID 15200323.  edit
  72. ^ Kuwano, R.; Kashiwabara, M.; Sato, K.; Ito, T.; Kaneda, K.; Ito, Y. (2006). "Catalytic asymmetric hydrogenation of indoles using a rhodium complex with a chiral bisphosphine ligand PhTRAP". Tetrahedron: Asymmetry 17 (4): 521. doi:10.1016/j.tetasy.2006.01.016.  edit
  73. ^ Kuwano, R.; Kashiwabara, M. (2006). "Ruthenium-Catalyzed Asymmetric Hydrogenation ofN-Boc-Indoles". Organic Letters 8 (12): 2653–2655. doi:10.1021/ol061039x. PMID 16737337.  edit
  74. ^ Baeza, A.; Pfaltz, A. (2010). "Iridium-Catalyzed Asymmetric Hydrogenation of N-Protected Indoles". Chemistry - A European Journal 16 (7): 2036. doi:10.1002/chem.200903105.  edit
  75. ^ a b Xiao, Y. C.; Wang, C.; Yao, Y.; Sun, J.; Chen, Y. C. (2011). "Direct Asymmetric Hydrosilylation of Indoles: Combined Lewis Base and Brønsted Acid Activation". Angewandte Chemie International Edition 50 (45): 10661. doi:10.1002/anie.201105341.  edit
  76. ^ Duan, Y.; Chen, M. W.; Ye, Z. S.; Wang, D. S.; Chen, Q. A.; Zhou, Y. G. (2011). "An Enantioselective Approach to 2,3-Disubstituted Indolines through Consecutive Brønsted Acid/Pd-Complex-Promoted Tandem Reactions". Chemistry - A European Journal 17 (26): 7193. doi:10.1002/chem.201100576.  edit
  77. ^ a b Kuwano, R.; Kashiwabara, M.; Ohsumi, M.; Kusano, H. (2008). "Catalytic Asymmetric Hydrogenation of 2,3,5-Trisubstituted Pyrroles". Journal of the American Chemical Society 130 (3): 808–809. doi:10.1021/ja7102422. PMID 18154340.  edit
  78. ^ a b Wang, D. S.; Ye, Z. S.; Chen, Q. A.; Zhou, Y. G.; Yu, C. B.; Fan, H. J.; Duan, Y. (2011). "Highly Enantioselective Partial Hydrogenation of Simple Pyrroles: A Facile Access to Chiral 1-Pyrrolines". Journal of the American Chemical Society 133 (23): 8866–8869. doi:10.1021/ja203190t. PMID 21591641.  edit
  79. ^ Wang, D. S.; Chen, Q. A.; Lu, S. M.; Zhou, Y. G. (2012). "Asymmetric Hydrogenation of Heteroarenes and Arenes". Chemical Reviews 112 (4): 2557–2590. doi:10.1021/cr200328h. PMID 22098109.  edit
  80. ^ Kaiser, S.; Smidt, S. P.; Pfaltz, A. (2006). "Iridium Catalysts with Bicyclic Pyridine–Phosphinite Ligands: Asymmetric Hydrogenation of Olefins and Furan Derivatives". Angewandte Chemie International Edition 45 (31): 5194. doi:10.1002/anie.200601529.  edit
  81. ^ Urban, S.; Beiring, B.; Ortega, N.; Paul, D.; Glorius, F. (2012). "Asymmetric Hydrogenation of Thiophenes and Benzothiophenes". Journal of the American Chemical Society 134 (37): 15241–15244. doi:10.1021/ja306622y. PMID 22934527.  edit
  82. ^ a b Heitbaum, M.; Glorius, F.; Escher, I. (2006). "Asymmetric Heterogeneous Catalysis". Angewandte Chemie International Edition 45 (29): 4732–62. doi:10.1002/anie.200504212. PMID 16802397.  edit
  83. ^ Yoon, M.; Srirambalaji, R.; Kim, K. (2012). "Homochiral Metal–Organic Frameworks for Asymmetric Heterogeneous Catalysis". Chemical Reviews 112 (2): 1196–1231. doi:10.1021/cr2003147. PMID 22084838.  edit
  84. ^ Hu, A.; Ngo, H. L.; Lin, W. (2003). "Chiral Porous Hybrid Solids for Practical Heterogeneous Asymmetric Hydrogenation of Aromatic Ketones". Journal of the American Chemical Society 125 (38): 11490–11491. doi:10.1021/ja0348344. PMID 13129339.  edit
  85. ^ Blaser, H. U.; Spindler, F.; Studer, M. (2001). "Enantioselective catalysis in fine chemicals production". Applied Catalysis A: General 221: 119. doi:10.1016/S0926-860X(01)00801-8.  edit
  86. ^ Blaser, Hans-Ulrich; Federsel, Hans-Jürgen, eds. (2010). Asymmetric Catalysis on Industrial Scale. Weinheim: Wiley-VCH. pp. 13–16. doi:10.1002/9783527630639. ISBN 9783527630639. 
  87. ^ Jacobsen, E.N.; Pfaltz, Andreas; Yamamato, H., eds. (1999). Comprehensive Asymmetric Catalysis. Berlin; New York: Springer. pp. 1443–1445. ISBN 3540643362.